Scalper1 News
Three leading medical-equipment stocks were up Thursday after reporting strong Q4 results, though their guidance continued this season’s theme of foreign-exchange headwinds. Life-science toolmaker Thermo Fisher Scientific (TMO) reported earnings minus one-time items of $1.99 a share, up 39% over the year-earlier quarter and beating analysts’ consensus by 5 cents. Sales rose 30% to $4.49 billion, topping estimates by more than $100 million. For the Scalper1 News
Scalper1 News